| News

Basel is the most popular Swiss location for headquarters

23.04.2020

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Novartis global headquarter in Basel (img: Mark Niedermann)

Last year, 912 international companies established their headquarters abroad according to an article by fDi Intelligence on the new rankings. fDi Intelligence has listed the top 30 European locations for headquarters in relation to the number of inhabitants based on the figures. While first place is taken by Dublin, Basel is the best-placed Swiss city at number eight. Geneva is also listed in 19th place.

The list generally illustrates the prevailing position of sites in the United Kingdom. As such, after Dublin and Amsterdam, come Reading and Warwick. Galway in Ireland takes fifth place above Vantaa in Finland. Cork in Ireland (7th), London (9th) and Luxembourg round off the top ten. Munich (17th), Dusseldorf (20th) and Frankfurt (29th) are other German-speaking cities to make it into the top 30.

Data from 2015 to 2019 was considered to create the list. For this, the investments required to establish the headquarters per 100,000 inhabitants of the respective city were used as well as other capital investments and the creation of jobs per 100,000 inhabitants.

You may also be interested in

Basel Area Business & Innovation, Invest

Syngenta grows strongly and stays true to Basel

Syngenta AG, Adama and Sinochem are to be united under the umbrella of the new Syngenta Group. The group is headquartered in Basel and employs around 48,000 staff across over 100 countries.

Read More
Basel Area Business & Innovation, Invest

Ricola earns the trust of Switzerland

Ricola has been voted the most trustworthy brand in Switzerland. The manufacturer of herbal candy, which is based in the Basel Area, previously won this award in 2017.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
1 2 3 13